Table 2.

Clinicopathologic characteristics according to p53 overexpression

Characteristicsp53 overexpression
P*
NoYes
Patients [n (%)]121 (79.6)31 (20.4)
Age, y (mean ± SD)50.3 ± 10.753.3 ± 12.1NS
Parity (mean ± SD)2.2 ± 1.62.2 ± 1.8NS
Body mass index, kg/m2 (mean ± SD)25.9 ± 4.524.5 ± 3.9NS
Menopausal status [n (%)]
    Premenopausal57 (83.8)11 (16.2)NS
    Postmenopausal64 (76.2)20 (23.8)
Histotype [n (%)]
    Endometrioid118 (80.3)29 (19.7)NS
    Others3 (60.0)2 (40.0)
International Federation of Gynecology and Obstetrics stage [n (%)]
    I, II106 (84.8)19 (15.2)0.001
    III, IV15 (55.6)12 (44.4)
Grade [n (%)]
    182 (93.2)6 (6.8)<0.001
    2 or 339 (60.9)25 (39.1)
Lymph node metastasis [n (%)]
    Negative90 (81.8)20 (18.2)0.012
    Positive8 (53.3)7 (46.7)
Myometrial invasion [n (%)]
    Less than half99 (86.1)16 (13.9)<0.001
    More than half22 (59.5)15 (40.5)
  • * By the t test or the χ2 test.

  • Papillary serous or clear cell type.

  • Lymph node dissection was not done in 27 cases.